ES2675018T3 - Sodium Reduced Food Products - Google Patents
Sodium Reduced Food Products Download PDFInfo
- Publication number
- ES2675018T3 ES2675018T3 ES14705945.5T ES14705945T ES2675018T3 ES 2675018 T3 ES2675018 T3 ES 2675018T3 ES 14705945 T ES14705945 T ES 14705945T ES 2675018 T3 ES2675018 T3 ES 2675018T3
- Authority
- ES
- Spain
- Prior art keywords
- ppm
- compound
- compounds
- use according
- sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 title claims description 11
- 229910052708 sodium Inorganic materials 0.000 title claims description 11
- 239000011734 sodium Substances 0.000 title claims description 11
- 235000013305 food Nutrition 0.000 title description 17
- 150000001875 compounds Chemical class 0.000 claims abstract description 101
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 38
- 239000011780 sodium chloride Substances 0.000 claims abstract description 20
- 229930014626 natural product Natural products 0.000 claims abstract description 11
- 235000014347 soups Nutrition 0.000 claims abstract description 9
- 150000003839 salts Chemical class 0.000 claims description 25
- 235000019643 salty taste Nutrition 0.000 claims description 21
- 150000001450 anions Chemical class 0.000 claims description 3
- 230000000813 microbial effect Effects 0.000 claims description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- 229910052744 lithium Inorganic materials 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 claims 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims 1
- 229910002651 NO3 Inorganic materials 0.000 claims 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 claims 1
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- 229940125797 compound 12 Drugs 0.000 claims 1
- 229930195712 glutamate Natural products 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 235000002639 sodium chloride Nutrition 0.000 description 38
- 239000000796 flavoring agent Substances 0.000 description 31
- 235000019634 flavors Nutrition 0.000 description 31
- 239000000203 mixture Substances 0.000 description 28
- 230000008447 perception Effects 0.000 description 20
- 235000019640 taste Nutrition 0.000 description 10
- 230000000975 bioactive effect Effects 0.000 description 9
- 238000000034 method Methods 0.000 description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 3
- 102000004310 Ion Channels Human genes 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 235000002567 Capsicum annuum Nutrition 0.000 description 2
- 240000004160 Capsicum annuum Species 0.000 description 2
- 206010013911 Dysgeusia Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 244000062241 Kaempferia galanga Species 0.000 description 2
- 235000013421 Kaempferia galanga Nutrition 0.000 description 2
- 244000025272 Persea americana Species 0.000 description 2
- 235000011236 Persea americana var americana Nutrition 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 239000001511 capsicum annuum Substances 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- -1 salt cations Chemical class 0.000 description 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- 241000906543 Actaea racemosa Species 0.000 description 1
- 241000157282 Aesculus Species 0.000 description 1
- 244000082872 Alchemilla vulgaris Species 0.000 description 1
- 235000000008 Alchemilla vulgaris Nutrition 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 235000007070 Angelica archangelica Nutrition 0.000 description 1
- 241000722948 Apocynum cannabinum Species 0.000 description 1
- 240000005343 Azadirachta indica Species 0.000 description 1
- 240000003890 Commiphora wightii Species 0.000 description 1
- 240000003098 Embelia ribes Species 0.000 description 1
- 235000018436 Embelia ribes Nutrition 0.000 description 1
- 239000001653 FEMA 3120 Substances 0.000 description 1
- 244000303564 Ferula assa foetida Species 0.000 description 1
- 235000007162 Ferula assa foetida Nutrition 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 235000010701 Lavanda vera Nutrition 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 235000019510 Long pepper Nutrition 0.000 description 1
- 244000137850 Marrubium vulgare Species 0.000 description 1
- 235000005321 Marrubium vulgare Nutrition 0.000 description 1
- 235000013500 Melia azadirachta Nutrition 0.000 description 1
- 244000097724 Mesua ferrea Species 0.000 description 1
- 235000010931 Mesua ferrea Nutrition 0.000 description 1
- 241000213947 Nephelium cuspidatum Species 0.000 description 1
- 240000005859 Orthosiphon aristatus Species 0.000 description 1
- 241000208317 Petroselinum Species 0.000 description 1
- 240000003455 Piper longum Species 0.000 description 1
- 241001069874 Pithecoctenium Species 0.000 description 1
- 244000236480 Podophyllum peltatum Species 0.000 description 1
- 235000008562 Podophyllum peltatum Nutrition 0.000 description 1
- 240000001679 Psidium guajava Species 0.000 description 1
- 235000013929 Psidium pyriferum Nutrition 0.000 description 1
- 238000001604 Rao's score test Methods 0.000 description 1
- 240000000528 Ricinus communis Species 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 241000304195 Salvia miltiorrhiza Species 0.000 description 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 1
- 241001078983 Tetradium ruticarpum Species 0.000 description 1
- 108050004388 Transient receptor potential cation channel subfamily V member 1 Proteins 0.000 description 1
- 244000063464 Vitex agnus-castus Species 0.000 description 1
- 241001640194 Xysmalobium undulatum Species 0.000 description 1
- 235000004552 Yucca aloifolia Nutrition 0.000 description 1
- 235000012044 Yucca brevifolia Nutrition 0.000 description 1
- 244000149006 Yucca filamentosa Species 0.000 description 1
- 235000017049 Yucca glauca Nutrition 0.000 description 1
- 244000131415 Zanthoxylum piperitum Species 0.000 description 1
- 235000008853 Zanthoxylum piperitum Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000005301 cimicifuga racemosa Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 235000021023 sodium intake Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000019583 umami taste Nutrition 0.000 description 1
- 241001446247 uncultured actinomycete Species 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L23/00—Soups; Sauces; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/40—Table salts; Dietetic salt substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/40—Table salts; Dietetic salt substitutes
- A23L27/45—Salt substitutes completely devoid of sodium chloride
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/117—Flakes or other shapes of ready-to-eat type; Semi-finished or partly-finished products therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Seasonings (AREA)
- Seeds, Soups, And Other Foods (AREA)
- Grain Derivatives (AREA)
- Meat, Egg Or Seafood Products (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
- General Preparation And Processing Of Foods (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Dairy Products (AREA)
- Confectionery (AREA)
Abstract
El uso de por lo menos un compuesto (a) que se sintetiza o deriva de un producto natural y se selecciona del grupo que consiste en los siguientes compuestos:**Fórmula** en el que el compuesto (a) se separa de su medio natural si se deriva de un producto natural, para sustituir al cloruro de sodio en una sopa.The use of at least one compound (a) that is synthesized or derived from a natural product and is selected from the group consisting of the following compounds: ** Formula ** in which the compound (a) separates from its medium natural if derived from a natural product, to replace sodium chloride in a soup.
Description
55
1010
15fifteen
20twenty
2525
3030
3535
4040
45Four. Five
50fifty
5555
6060
6565
DESCRIPCIONDESCRIPTION
Productos alimenticios reducidos en sodio CAMPOSodium reduced food products FIELD
Esta invención se refiere al uso de ciertos compuestos para sustituir cloruro de sodio en una sopa.This invention relates to the use of certain compounds to substitute sodium chloride in a soup.
ANTECEDENTESBACKGROUND
El cloruro de sodio, sal de mesa ordinaria, es el compuesto prototípico para provocar la percepción del sabor salado. Sin embargo, los intentos de reducir el consumo de sodio han conducido a los investigadores a encontrar sustitutos apropiados para el cloruro de sodio o a reducir las cantidades de cloruro de sodio, sin sacrificar el sabor salado.Sodium chloride, ordinary table salt, is the prototypic compound to cause the perception of salty taste. However, attempts to reduce sodium intake have led researchers to find appropriate substitutes for sodium chloride or to reduce the amounts of sodium chloride, without sacrificing the salty taste.
Las sales pueden provocar sabores complejos, que incluyen mezclas de componentes de percepción dulces, amargos, agrios, umami y salados. Se cree que los cationes de sales imparten el componente de percepción de sabor, mientras que los aniones, además de contribuir a los sabores propios, modifican la percepción del sabor de los cationes. A modo de ejemplo, se cree que el sodio y el litio imparten solo sabores salados, mientras que el potasio y otros cationes alcalinotérreos producen sabores tanto salados como amargos. Entre los aniones que se encuentran comúnmente en los alimentos, el ion cloruro se considera el menos inhibidor del sabor salado, mientras que el anión citrato es más inhibidor.Salts can cause complex flavors, including mixtures of sweet, sour, sour, umami and salty perception components. It is believed that the salt cations impart the flavor perception component, while the anions, in addition to contributing to their own flavors, modify the perception of the flavor of the cations. As an example, it is believed that sodium and lithium impart only salty flavors, while potassium and other alkaline earth cations produce both salty and bitter flavors. Among the anions that are commonly found in foods, the chloride ion is considered the least salty taste inhibitor, while the citrate anion is more inhibitor.
Se han realizado muchos intentos para proporcionar composiciones de sabor salado como un sustituto de la sal de mesa que dará el mismo o un efecto de condimento similar y que están compuestas por cantidades sustancialmente reducidas de cloruro de sodio. Con este fin, se han sugerido cloruro de potasio, cloruro de amonio y compuestos similares. El uso de tales sales, y combinaciones de tales sales, deja mucho que desear en cuanto al sabor. Ninguno de ellos individualmente o en combinación afecta positivamente a otras modalidades de sabor y sabe a cloruro de sodio. Cada uno solo tiene un sabor desagradable, al igual que las mezclas de tales sales. Por ejemplo, el cloruro de potasio tiene un fuerte regusto que es caracterizado como "amargo" por la mayoría de las personas. El cloruro de amonio también tiene un regusto amargo.Many attempts have been made to provide salty flavor compositions as a substitute for table salt that will give the same or a similar seasoning effect and that are composed of substantially reduced amounts of sodium chloride. To this end, potassium chloride, ammonium chloride and similar compounds have been suggested. The use of such salts, and combinations of such salts, leaves much to be desired in terms of taste. None of them individually or in combination positively affects other taste modalities and tastes like sodium chloride. Each has only an unpleasant taste, as do mixtures of such salts. For example, potassium chloride has a strong aftertaste that is characterized as "bitter" by most people. Ammonium Chloride also has a bitter aftertaste.
SUMARIOSUMMARY
Esta descripción describe, entre otras cosas, compuestos que provocan o mejoran la percepción del sabor salado, u otro sabor complejo asociado con el consumo de cloruro sódico, o que interactúan con un receptor o canal iónico asociado con la percepción de salado sabor u otro sabor complejo asociado con el consumo de cloruro de sodio. En realizaciones, los compuestos bioactivos son compuestos moduladores del sabor usados como ingredientes en productos alimenticios para provocar o mejorar la percepción del sabor salado. En realizaciones, los productos alimentarios contienen cantidades de sodio menores de lo normal. Preferentemente, los compuestos moduladores del sabor son compuestos bioactivos capaces de ser derivados de productos naturales.This description describes, among other things, compounds that cause or improve the perception of salty taste, or other complex flavor associated with the consumption of sodium chloride, or that interact with a receptor or ion channel associated with the perception of salty taste or other flavor. complex associated with the consumption of sodium chloride. In embodiments, bioactive compounds are flavor modulating compounds used as ingredients in food products to cause or improve the perception of salty taste. In embodiments, food products contain lower than normal amounts of sodium. Preferably, flavor modulating compounds are bioactive compounds capable of being derived from natural products.
Según esta invención, por lo menos un compuesto seleccionado de entre los compuestos (10), (12), (13), (16), (29), (33), (36), (37), (41), (43), (44), (45), (48), (53), (56), (66), (73), (82), (83), y (84) descritos a continuación se usa para sustituir el cloruro de sodio en una sopa.According to this invention, at least one compound selected from among the compounds (10), (12), (13), (16), (29), (33), (36), (37), (41), (43), (44), (45), (48), (53), (56), (66), (73), (82), (83), and (84) described below are used to Replace the sodium chloride in a soup.
Una o más realizaciones de los compuestos, composiciones, productos alimentarios o métodos descritos aquí proporcionan una o más ventajas sobre los compuestos, composiciones, productos alimenticios o métodos anteriores. Por ejemplo, los productos alimentarios que incluyen uno o más compuestos salados o que modulan el sabor descritos aquí pueden tener un menor contenido de sodio en relación con los productos alimentarios que no incluyen dichos compuestos salados o moduladores del sabor mientras imparten un nivel similar de salinidad. Esta y otras ventajas se entenderán fácilmente a partir de la siguiente descripción detallada.One or more embodiments of the compounds, compositions, food products or methods described herein provide one or more advantages over the above compounds, compositions, food products or methods. For example, food products that include one or more salty compounds or that modulate the taste described herein may have a lower sodium content in relation to food products that do not include such salty compounds or flavor modulators while imparting a similar level of salinity . This and other advantages will be easily understood from the following detailed description.
BREVE DESCRIPCIÓN DE LOS DIBUJOSBRIEF DESCRIPTION OF THE DRAWINGS
La FIGURA 1 es una tabla que proporciona resultados de la prueba de puntuación del DAP con respecto a la percepción de la salinidad de varias combinaciones de compuestos en disolución de cloruro de sodio.FIGURE 1 is a table that provides results of the DAP scoring test with respect to the salinity perception of various combinations of compounds in sodium chloride solution.
La FIGURA 2 es una tabla que proporciona resultados de la prueba de puntuación del DAP con respecto a la percepción de la salinidad de varias combinaciones de compuestos en combinación en disolución de caldo.FIGURE 2 is a table that provides DAP score test results regarding the salinity perception of various combinations of compounds in combination in broth solution.
DESCRIPCIÓN DETALLADADETAILED DESCRIPTION
La presente invención se refiere al uso de por lo menos un compuesto seleccionado de entre los compuestos (10), (12), (13), (16), (29), (33), (36), (37), (41), (43), (44), (45), (48), (53), (56), (66), (73), (82), (83),y (84) descritos a continuación para sustituir el cloruro de sodio en una sopa.The present invention relates to the use of at least one compound selected from among the compounds (10), (12), (13), (16), (29), (33), (36), (37), (41), (43), (44), (45), (48), (53), (56), (66), (73), (82), (83), and (84) described a then to replace the sodium chloride in a soup.
Todos los términos científicos y técnicos usados aquí tienen significados comúnmente usados en la técnica, a menos que se especifique lo contrario. Las definiciones proporcionadas aquí son para facilitar la comprensión de ciertos términos usados con frecuencia aquí y no se pretende que limiten el alcance de la presente descripción.All scientific and technical terms used here have meanings commonly used in the art, unless otherwise specified. The definitions provided here are to facilitate the understanding of certain terms frequently used here and are not intended to limit the scope of this description.
Tal como se usa en esta memoria descriptiva y en las reivindicaciones adjuntas, las formas en singular "un", "una" yAs used herein and in the appended claims, the singular forms "a", "a" and
55
1010
15fifteen
20twenty
2525
3030
3535
4040
45Four. Five
50fifty
5555
6060
6565
"el" incluyen realizaciones que tiene referentes plurales, a menos que el contenido indique claramente lo contrario."el" includes embodiments that have plural referents, unless the content clearly indicates otherwise.
Tal como se usa en esta memoria descriptiva y en las reivindicaciones adjuntas, el término "o" se emplea generalmente en su sentido que incluye "y/o" a menos que el contenido indique claramente lo contrario. El término "y/o" quiere decir uno o todos los elementos enumerados o una combinación de dos o más de los elementos enumerados.As used herein and in the appended claims, the term "or" is generally used in its sense that includes "and / or" unless the content clearly indicates otherwise. The term "and / or" means one or all of the items listed or a combination of two or more of the items listed.
Tal como se usa aquí, "tiene", "que tiene", "incluye", "que incluye", "comprende", "que comprende" o similares se usan en su sentido abierto, y generalmente quiere decir "que incluye, pero no limitado a". Se entenderá que "que consiste esencialmente en", "que consiste en", y similares se incluyen en "que comprende "y similares. Tal como se usa aquí, "que consiste esencialmente en", en lo que se refiere a una composición, producto, método o similares, quiere decir que los componentes de la composición, producto, método o similares están limitados a los componentes enumerados y cualquier otro componente que no afecte materialmente a la(s) característica(s) básica(s) y nueva(s) de la composición, producto, método o similares.As used herein, "it has", "it has", "it includes", "it includes", "it includes", "it comprises" or the like is used in its open sense, and it generally means "that includes, but not limited to ". It will be understood that "consisting essentially of", "consisting of", and the like are included in "comprising" and the like. As used herein, "consisting essentially of", as regards a composition, product, method or the like, it means that the components of the composition, product, method or the like are limited to the listed components and any another component that does not materially affect the basic (s) and new (s) characteristic (s) of the composition, product, method or the like.
Las palabras "preferido" y "preferentemente" se refieren a realizaciones de la invención que pueden proporcionar ciertos beneficios, en ciertas circunstancias. Sin embargo, también se pueden preferir otras realizaciones, en las mismas u otras circunstancias. Además, la citación de una o más realizaciones preferidas no implica que otras realizaciones no sean útiles, y no se pretende excluir otras realizaciones del alcance de la descripción, incluyendo las reivindicaciones.The words "preferred" and "preferably" refer to embodiments of the invention that may provide certain benefits, in certain circumstances. However, other embodiments may also be preferred, in the same or other circumstances. In addition, the citation of one or more preferred embodiments does not imply that other embodiments are not useful, and it is not intended to exclude other embodiments from the scope of the description, including the claims.
También aquí, las citaciones de intervalos numéricos por puntos finales incluyen todos los números incluidos dentro de ese intervalo (por ejemplo, de 1 a 5 incluye 1, 1,5, 2, 2,75, 3, 3,80, 4, 5, etc. o 10 o menos incluye 10, 9,4, 7,6, 5, 4,3, 2,9, 1,62, 0,3, etc.). Cuando un intervalo de valores es "hasta" un valor particular, ese valor se incluye dentro del intervalo.Also here, citations of numerical intervals by endpoints include all numbers included within that range (for example, 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, 5 , etc. or 10 or less includes 10, 9.4, 7.6, 5, 4.3, 2.9, 1.62, 0.3, etc.). When a range of values is "up to" a particular value, that value is included within the range.
Tal como se usa aquí, un “producto alimentario” es un alimento producido mezclando dos o más ingredientes comestibles.As used herein, a "food product" is a food produced by mixing two or more edible ingredients.
Tal como se usa aquí, un "compuesto bioactivo" es un compuesto que interacciona con un receptor o canal iónico asociado con la percepción del sabor salado u otro sabor asociado con el consumo de cloruro de sodio.As used herein, a "bioactive compound" is a compound that interacts with an ionic receptor or channel associated with the perception of salty taste or other flavor associated with the consumption of sodium chloride.
Tal como se usa aquí, un "compuesto modulador del sabor" es un compuesto que modifica el sabor de un producto alimentario. A modo de ejemplo, un compuesto modulador del sabor puede modificar el sabor de un producto alimentario debido a un sabor particular impartido por el compuesto modulador del sabor, debido a una modificación del sabor percibido del producto alimentario, o uno de sus componente, o similares. En realizaciones, un compuesto modulador del sabor es un compuesto modulador del sabor salado.As used herein, a "flavor modulator compound" is a compound that modifies the taste of a food product. By way of example, a flavor modulating compound may modify the taste of a food product due to a particular taste imparted by the flavor modulating compound, due to a modification of the perceived taste of the food product, or one of its components, or the like. . In embodiments, a flavor modulator compound is a salt flavor modulator compound.
Tal como se usa aquí, un "compuesto modulador del sabor salado" es un compuesto que, cuando se ingiere, (i) provoca o potencia una percepción del sabor salado solo o en presencia de una sal, tal como cloruro de sodio o (ii) altera el flujo de iones a través de uno o más canales iónicos asociados con la percepción del sabor salado. Los ejemplos de canales iónicos asociados a la percepción del sabor salado incluyen el canal ENaC, el canal TrpV1, y el canal TrpML3.As used herein, a "salty taste modulating compound" is a compound that, when ingested, (i) causes or enhances a perception of salty taste alone or in the presence of a salt, such as sodium chloride or (ii ) alters the flow of ions through one or more ion channels associated with the perception of salty taste. Examples of ion channels associated with the perception of salty taste include the ENaC channel, the TrpV1 channel, and the TrpML3 channel.
Tal como se usa aquí, un compuesto "derivado" de un producto natural es un compuesto que existe en un producto natural, cuya identidad se verifica. Un compuesto sintetizado puede ser un compuesto derivado de un producto natural, con tal de que el compuesto sintetizado sea un compuesto que existe en el producto natural.As used herein, a compound "derived" from a natural product is a compound that exists in a natural product, whose identity is verified. A synthesized compound can be a compound derived from a natural product, as long as the synthesized compound is a compound that exists in the natural product.
Tal como se usa aquí, un compuesto "aislado" o "purificado" es un compuesto que se separa sustancialmente de otros componentes de la fuente del compuesto. Por ejemplo, si la fuente del compuesto es un producto natural, un compuesto aislado o purificado puede ser un compuesto que se separa de su medio natural. Si el compuesto es sintetizado, el compuesto se puede separar de los reactivos, subproductos de reacción, disolventes o similares sin reaccionar.As used herein, an "isolated" or "purified" compound is a compound that is substantially separated from other components of the source of the compound. For example, if the source of the compound is a natural product, an isolated or purified compound may be a compound that separates from its natural environment. If the compound is synthesized, the compound can be separated from unreacted reagents, reaction by-products, solvents or the like.
En realizaciones, una composición que incluye un compuesto modulador del sabor salado se percibe como que imparte una cantidad de salinidad igual a una composición sustancialmente similar que no incluye el compuesto modulador del sabor salado pero que tiene una mayor concentración de la sal. Preferentemente, la composición que incluye el compuesto modulador del sabor salado imparte una percepción de salinidad igual a la composición sustancialmente similar que no tiene el compuesto modulador del sabor salado cuando la composición tiene alrededor de 1% o menos sal que la composición sustancialmente similar. Por ejemplo, la composición que incluye el compuesto modulador del sabor salado puede impartir una percepción de salinidad igual a la composición sustancialmente similar que no tiene el compuesto salado cuando la composición tiene alrededor de 2% o menos, alrededor de 5% o menos, alrededor de 7% o menos, alrededor de 8% o menos, alrededor de 9% o menos, alrededor de 10% o menos, alrededor de 11% o menos, alrededor de 15% o menos, alrededor de 20% o menos, alrededor de 30% o menos, alrededor de 35% o menos, alrededor de 40% o menos, o alrededor de 50% o menosIn embodiments, a composition that includes a salt flavor modulator compound is perceived as imparting an amount of salinity equal to a substantially similar composition that does not include the salt flavor modulator compound but has a higher salt concentration. Preferably, the composition that includes the salty taste modulating compound imparts a perception of salinity equal to the substantially similar composition that the salty flavor modulating compound does not have when the composition has about 1% or less salt than the substantially similar composition. For example, the composition that includes the salty taste modulating compound may impart a salinity perception equal to the substantially similar composition that the salty compound does not have when the composition is about 2% or less, about 5% or less, about 7% or less, about 8% or less, about 9% or less, about 10% or less, about 11% or less, about 15% or less, about 20% or less, about 30% or less, about 35% or less, about 40% or less, or about 50% or less
55
1010
15fifteen
20twenty
2525
3030
3535
4040
45Four. Five
50fifty
5555
6060
que la composición sustancialmente similar. En otras palabras, uno o más compuestos moduladores del sabor salado pueden estar presentes en un producto alimentario en una cantidad suficiente para reducir la cantidad de una sal, tal como cloruro de sodio, en alrededor de 1% o más, alrededor de 2% o más, alrededor de 5% o más, alrededor de 7% o más, alrededor de 8% o más, alrededor de 10% o más, alrededor de 11% o más, alrededor de 12% o más, alrededor de 15% o más, alrededor de 20% o más, alrededor de 22% o más, alrededor de 25% o más, alrededor de 30% o más, alrededor de 35% o más, alrededor de 40% o más, alrededor de 45% o más, alrededor de 50% o más, alrededor de 55% o más, alrededor de 60% o más, alrededor de 65% o más, alrededor de 70% o más, alrededor de 75% o más, alrededor de 80% o más, alrededor de 85% o más, alrededor de 90% o más, alrededor de 95% o más, o similares. El producto alimentario reducido en sal provoca la misma o similar percepción de la salinidad que un producto alimentario sustancialmente similar que no incluye uno o más compuestos moduladores del sabor salado.than the substantially similar composition. In other words, one or more salt flavor modulating compounds may be present in a food product in an amount sufficient to reduce the amount of a salt, such as sodium chloride, by about 1% or more, about 2% or more, about 5% or more, about 7% or more, about 8% or more, about 10% or more, about 11% or more, about 12% or more, about 15% or more , about 20% or more, about 22% or more, about 25% or more, about 30% or more, about 35% or more, about 40% or more, about 45% or more, about 50% or more, about 55% or more, about 60% or more, about 65% or more, about 70% or more, about 75% or more, about 80% or more, about 85% or more, about 90% or more, about 95% or more, or the like. The reduced salt food product causes the same or similar perception of salinity as a substantially similar food product that does not include one or more salty flavor modulating compounds.
La percepción de salinidad se puede evaluar de cualquier manera apropiada. En realizaciones, la salinidad se determina por un panel sensorial analítico entrenado. En realizaciones, el panel sensorial entrenado determina la salinidad de una composición que tiene un compuesto modulador del sabor salado con relación a una composición sustancialmente similar que tiene un contenido de cloruro sódico incrementado si un panel analítico sensorial entrenado determina primero que la composición y la composición sustancialmente similar solo difieren en sabor respecto a la salinidad.The perception of salinity can be evaluated in any appropriate way. In embodiments, salinity is determined by a trained analytical sensory panel. In embodiments, the trained sensory panel determines the salinity of a composition that has a salty taste modulating compound relative to a substantially similar composition that has an increased sodium chloride content if a trained sensory analytical panel first determines that the composition and composition substantially similar only differ in taste with respect to salinity.
Un compuesto modulador del sabor salado puede ser un compuesto que directamente actúa para provocar o mejorar la percepción del sabor salado de una sal o puede ser un compuesto que se convierte, cuando se ingiere, en un compuesto que actúa directamente para provocar la mejora de la percepción del sabor salado de la sal.A salty taste modulating compound can be a compound that directly acts to cause or improve the perception of the salty taste of a salt or it can be a compound that becomes, when ingested, a compound that acts directly to cause the improvement of perception of the salty taste of salt.
Para los propósitos de esta descripción, la referencia a un compuesto incluye la referencia a sales del compuesto, hidratos del compuesto, polimorfos del compuesto, isómeros del compuesto (incluyendo isómeros constitucionales y estereoisómeros tales como enantiómeros y diasterómeros) y similares.For the purposes of this description, reference to a compound includes reference to salts of the compound, hydrates of the compound, polymorphs of the compound, isomers of the compound (including constitutional isomers and stereoisomers such as enantiomers and diastereomers) and the like.
Tal como se usa aquí, una composición que es "sustancialmente similar" a otra composición contiene sustancialmente la misma concentración de componentes (por ejemplo, dentro de alrededor de 5%) a excepción de los componentes específicamente enumerados que hacen las composiciones diferentes. Por ejemplo, una composición que incluye un compuesto salado puede ser sustancialmente similar a una composición que no tiene el compuesto salado, si los componentes de las composiciones, aparte de la sal y el compuesto salado, están presentes en una concentración sustancialmente similarAs used herein, a composition that is "substantially similar" to another composition contains substantially the same concentration of components (for example, within about 5%) except for the specifically listed components that make the different compositions. For example, a composition that includes a salted compound may be substantially similar to a composition that does not have the salted compound, if the components of the compositions, apart from the salt and the salted compound, are present in a substantially similar concentration
Tal como se usa aquí, un compuesto bioactivo, modulador del sabor o modulador del sabor salado que se deriva de un "producto natural” es un compuesto que se extrae de, por ejemplo, una fuente vegetal o microbiana en contraposición a ser producido sintéticamente. La extracción o aislamiento del compuesto bioactivo modulador del sabor, modulador del sabor salado de origen natural se puede facilitar mediante reacciones químicas simples tales como acidificación, basificación, intercambio iónico, hidrólisis y formación de sal, así como fermentación microbiana y similares. En realizaciones, un compuesto bioactivo, modulador del sabor, o modulador del sabor salado se deriva de fuentes naturales tales como plantas, hongos y fuentes bacterianas. Los ejemplos de tales fuentes naturales incluyen, pero no se limitan a, Aesculus hippocastaneum; Alchemilla xanthochlora; Angelica archangelica; Apocynum cannabinum; Azadirachta indica; Bacteria Actinomycete (código de cepa: 01702axxx000002); Capsicum annuum; Cimicifuga racemosa; Commiphora mukul; Embelia ribes; Evodia rutaecarpa; Ferula assa-foetida; Hongos (Código de cepa: 02295fxxx000001; Código de cepa: 01469fxxx000005); Gleditschia australis; Kaempferia galanga; Lavandula officinalis; Marrubium vulgare; Mesua ferrea; Nephelium cuspidatum; Orthosiphon stamineus; Persea gratissima; Petroselinum stativum; Piper longum; Pithecoctenium echinatum; Podophyllum peltatum; Psidium guajava; Ricinus communis; Salviamiltiorrhiza; Schisandea chinensis; Teclea trichocarpa; Vitex agnus; Xysmalobium undulatum; Yucca gloriosa; Zanthoxylumpiperitum; Zingiber officinalis; y otros. En realizaciones, uno o más compuestos derivados de Persea gratissima se combinan con uno o más compuestos derivados de Kaempferia galanga o uno o más compuestos derivados de Capsicum annuum; y otros.As used herein, a bioactive compound, flavor modulator or salt flavor modulator that is derived from a "natural product" is a compound that is extracted from, for example, a plant or microbial source as opposed to being synthetically produced. The extraction or isolation of the bioactive compound that modulates flavor, modulates the salty flavor of natural origin can be facilitated by simple chemical reactions such as acidification, basification, ion exchange, hydrolysis and salt formation, as well as microbial fermentation and the like. a bioactive compound, flavor modulator, or salty taste modulator is derived from natural sources such as plants, fungi and bacterial sources.Examples of such natural sources include, but are not limited to, Aesculus hippocastaneum; Alchemilla xanthochlora; Angelica archangelica; Apocynum cannabinum; Azadirachta indica; Actinomycete bacteria (strain code: 01702axxx0000 02); Capsicum annuum; Cimicifuga racemosa; Commiphora mukul; Embelia ribes; Evodia rutaecarpa; Ferula assa-foetida; Fungi (strain code: 02295fxxx000001; strain code: 01469fxxx000005); Gleditschia australis; Kaempferia galanga; Lavandula officinalis; Marrubium vulgare; Mesua iron; Nephelium cuspidatum; Orthosiphon stamineus; Persea gratissima; Petroselinum stativum; Piper longum; Pithecoctenium echinatum; Podophyllum peltatum; Psidium guajava; Ricinus communis; Salviamiltiorrhiza; Schisandea chinensis; Type trichocarpa; Vitex agnus; Xysmalobium undulatum; Glorious Yucca; Zanthoxylumpiperitum; Zingiber officinalis; and others. In embodiments, one or more compounds derived from Persea gratissima are combined with one or more compounds derived from Kaempferia galanga or one or more compounds derived from Capsicum annuum; and others.
COMPUESTOS BIOACTIVOS MODULADORES DEL SABOR, Y MODULADORES DEL SABOR SALADO Se presentan aquí compuestos de origen natural que se ha identificado que provocan o mejoran la percepción de salinidad, y clases de compuestos derivados de ellos.BIOACTIVE COMPOUNDS MODULATORS OF FLAVOR, AND MODULATORS OF SALT FLAVOR Compounds of natural origin that have been identified that cause or improve the perception of salinity, and classes of compounds derived from them are presented here.
En realizaciones, un compuesto bioactivo, modulador del sabor, o modulador del sabor salado es un compuesto que tiene la siguiente estructura (A) que no está incluida en las reivindicacionesIn embodiments, a bioactive compound, flavor modulator, or salty taste modulator is a compound having the following structure (A) that is not included in the claims
en la que:in which:
55
1010
15fifteen
20twenty
2525
3030
R1 es H o alquilo de C1-C10;R1 is H or C1-C10 alkyl;
R2 es H o alquilo de C1-C3;R2 is H or C1-C3 alkyl;
X es CHOR3 o C=O;X is CHOR3 or C = O;
R3 es H o alquilo de C1-C3; oR3 is H or C1-C3 alkyl; or
OOR
--------C-------R4--------- C ------- R4-
R4 es H o alquilo de C1-C3;R4 is H or C1-C3 alkyl;
Y es CR5=CH o CHR5-CH2;Y is CR5 = CH or CHR5-CH2;
R5 es H, OH, -OCH3, -OCH2CH3, -O-OCH2CH2CH3, oR5 is H, OH, -OCH3, -OCH2CH3, -O-OCH2CH2CH3, or
OOR
--------O-------C-------R6;-------- OR ------- C ------- R6;
y 6and 6
R6 es H o alquiloR6 is H or alkyl
de C1-C6.of C1-C6.
En realizaciones, R1 esIn embodiments, R1 is
alquilo de C2-C8. En realizaciones, R2 es H. En realizaciones, X es C=O oC2-C8 alkyl. In embodiments, R2 is H. In embodiments, X is C = O or
oor
en la que R4 es CH3. En realizaciones, cuando Y es CR5=CH, R5 es H. En realizaciones, cuando Y es CHR5-CH2, R5 es OH o -OCH3. En realizaciones, R6 es CH3.in which R4 is CH3. In embodiments, when Y is CR5 = CH, R5 is H. In embodiments, when Y is CHR5-CH2, R5 is OH or -OCH3. In embodiments, R6 is CH3.
En realizaciones, un compuesto bioactivo, modulador del sabor, o modulador del sabor salado es un compuesto que tiene una o más de las siguientes estructuras (que no están incluidas en las reivindicaciones):In embodiments, a bioactive compound, flavor modulator, or salty taste modulator is a compound that has one or more of the following structures (which are not included in the claims):
Claims (19)
- Compuesto Compound
- 12 13 83 10 37 36 45 18 56 82 3 84 41 48 53 44 62 43 12 13 83 10 37 36 45 18 56 82 3 84 41 48 53 44 62 43
- Concentración Concentration
- 12 12
- l ppm X X X X X X X X X X X X X X X X X X l ppm X X X X X X X X X X X X X X X X X X
- 13 13
- 10 ppm 3.4 X X X X X X X X X X X X X X X X X 10 ppm 3.4 X X X X X X X X X X X X X X X X X
- 83 83
- 1 ppm 3.2; 4.2 3.7; 4.5 X X X X X X X X X X X X X X X X 1 ppm 3.2; 4.2 3.7; 4.5 X X X X X X X X X X X X X X X X
- 10 10
- 1 ppm 3.9 3.1 3.9 X X X X X. X X X X X X X X X X 1 ppm 3.9 3.1 3.9 X X X X X. X X X X X X X X X X
- 37 37
- 10 ppm 3.0; 4.4 3.5 4.1 4.1 X X X X X X X X X X X X X X 10 ppm 3.0; 4.4 3.5 4.1 4.1 X X X X X X X X X X X X X X
- 36 36
- 0.1 ppm 3.9 3.8 3.5 3.3; 3.4 3.1 X X X X X X X X X X X X X 0.1 ppm 3.9 3.8 3.5 3.3; 3.4 3.1 X X X X X X X X X X X X X
- 45 Four. Five
- 1 0 ppm 3.6; 3.9 3.4; 4.1 2.4; 3.4 3.4 3.3 4 X X X X X X X X X X X X 1.0 ppm 3.6; 3.9 3.4; 4.1 2.4; 3.4 3.4 3.3 4 X X X X X X X X X X X X
- 18 18
- 10 ppm 2.6; 4.0 3.1 3.2; 3.9 3.3 3.8 3.4 2.7: 3.3 X X X X X X X X X X X 10 ppm 2.6; 4.0 3.1 3.2; 3.9 3.3 3.8 3.4 2.7: 3.3 X X X X X X X X X X X
- 56 56
- 1 0 ppm 2.6 3.4 3.8 4.1 3.4; 4.4 3.1; 3.7 3.1 3.4 X X X X X X X X X X 1 0 ppm 2.6 3.4 3.8 4.1 3.4; 4.4 3.1; 3.7 3.1 3.4 X X X X X X X X X X
- 82 82
- 1 ppm 3.2 3.4 X X X X X X X X X 1 ppm 3.2 3.4 X X X X X X X X X
- 3 3
- 0.1 ppm 3.5 X X X X X X X X 0.1 ppm 3.5 X X X X X X X X
- 84 84
- 1 ppm 3.8 3.2 3.5 3.4 X X X X X X X 1 ppm 3.8 3.2 3.5 3.4 X X X X X X X
- 41 41
- 1 0 ppm '■> '•v J .3 3 3.1 X X X X X X 1 0 ppm '■>' • v J .3 3 3.1 X X X X X X
- 48 48
- 10 ppm 3.4 3.3 3.3 X X X X X 10 ppm 3.4 3.3 3.3 X X X X X
- 53 53
- 1 ppm 3.0 2.9 3.0 X X X X 1 ppm 3.0 2.9 3.0 X X X X
- 44 44
- 10 ppm 3.2 3.3 3.1 3 2.8 X X X 10 ppm 3.2 3.3 3.1 3 2.8 X X X
- 62 62
- 10 ppm 3.0 3.1 3.0 2.9 2.9 X X 10 ppm 3.0 3.1 3.0 2.9 2.9 X X
- 43 43
- 10 ppm 3.1 3.2 3.1 3.1 3.1 X 10 ppm 3.1 3.2 3.1 3.1 3.1 X
- Compuesto (Concentración) Compound (Concentration)
- 12 13 83 10 37 36 45 18 56 82 3 84 41 48 53 44 62 43 12 13 83 10 37 36 45 18 56 82 3 84 41 48 53 44 62 43
- 12 (1 ppm) 12 (1 ppm)
- X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X
- 13 (10 ppm) 13 (10 ppm)
- 7,9 X X X X X X X X X X X X X X X X X 7.9 X X X X X X X X X X X X X X X X X
- 83 (1 ppm) 83 (1 ppm)
- 8,0 7,9 X X X X X X X X X X X X X X X X 8.0 7.9 X X X X X X X X X X X X X X X X
- 1.0 (1 ppm) 1.0 (1 ppm)
- 7,7 7,9 7,9 X X X X X X X X X X X X X X X 7.7 7.9 7.9 X X X X X X X X X X X X X X X
- 37 (10 ppm) 37 (10 ppm)
- 8,1 X X X X X X X X X X X X X X 8.1 X X X X X X X X X X X X X X
- 36 (0,1 ppm) 36 (0.1 ppm)
- 8,! 7,8 7,8 X X X X X X X X X X X X X 8! 7.8 7.8 X X X X X X X X X X X X X
- 45 (10 ppm) 45 (10 ppm)
- 8,2 8,1 X X X X X X X. X X X X X 8.2 8.1 X X X X X X X. X X X X X
- 18 (10 ppm) 18 (10 ppm)
- 8,3- 9,0 8,0 8,1 8,0 7,9 X X X X X X X X X X X 8.3- 9.0 8.0 8.1 8.0 7.9 X X X X X X X X X X X
- 56 (10 ppm) 56 (10 ppm)
- 8,1 7,9 8,0 8,0 8,2 X X X X X X X X X X 8.1 7.9 8.0 8.0 8.2 X X X X X X X X X X
- 82 (1 ppm) 82 (1 ppm)
- 8,3 7,6 7,6 8,2 8,3 7,9 X X X X X X X X X 8.3 7.6 7.6 8.2 8.3 7.9 X X X X X X X X X
- 3 (0,1 ppm) 3 (0.1 ppm)
- 8,2 7,7 7,9 7,9 8,5 8,4 8,3 7,9 8,3 X X X X X X X X 8.2 7.7 7.9 7.9 8.5 8.4 8.3 7.9 8.3 X X X X X X X X
- 84 (1 ppm) 84 (1 ppm)
- 8,2 8,8 8,0 7,7 8,1 7,8 7,9 X X X X X X X 8.2 8.8 8.0 7.7 8.1 7.8 7.9 X X X X X X X
- 41 (10 ppm) 41 (10 ppm)
- 7,7 7,S 7,6 X X X X X X X 7.7 7, S 7.6 X X X X X X X
- 48 (10 ppm) 48 (10 ppm)
- 7,8 X X X X X X 7.8 X X X X X X
- 53 (1 ppm) 53 (1 ppm)
- 8,0 8,1 7,9 7,6 8,1 8,0 7,9 8,0 X X X X X 8.0 8.1 7.9 7.6 8.1 8.0 7.9 8.0 X X X X X
- 44 (10 ppm) 44 (10 ppm)
- 7,4 7,7 7,8 8,1 7,9 7,9 8,0 7,8 X X X X 7.4 7.7 7.8 8.1 7.9 7.9 8.0 7.8 X X X X
- 62 (10 ppm) 62 (10 ppm)
- 7,7 7,5 X X X 7.7 7.5 X X X
- 43 (10 ppm) 43 (10 ppm)
- 7,8 8,0 7,8 7,9 8,0 8,0 7,9 7,8 8,1 X X 7.8 8.0 7.8 7.9 8.0 8.0 7.9 7.8 8.1 X X
Applications Claiming Priority (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361762798P | 2013-02-08 | 2013-02-08 | |
US201361762792P | 2013-02-08 | 2013-02-08 | |
US201361762781P | 2013-02-08 | 2013-02-08 | |
US201361762804P | 2013-02-08 | 2013-02-08 | |
US201361762798P | 2013-02-08 | ||
US201361762792P | 2013-02-08 | ||
US201361762804P | 2013-02-08 | ||
US201361762781P | 2013-02-08 | ||
US201361763274P | 2013-02-11 | 2013-02-11 | |
US201361763244P | 2013-02-11 | 2013-02-11 | |
US201361763300P | 2013-02-11 | 2013-02-11 | |
US201361763244P | 2013-02-11 | ||
US201361763274P | 2013-02-11 | ||
US201361763300P | 2013-02-11 | ||
PCT/US2014/015244 WO2014124222A1 (en) | 2013-02-08 | 2014-02-07 | Reduced sodium food products |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2675018T3 true ES2675018T3 (en) | 2018-07-05 |
Family
ID=50138012
Family Applications (7)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES18201716T Active ES2925071T3 (en) | 2013-02-08 | 2014-02-07 | Reduced sodium food products |
ES18164825T Active ES2831028T3 (en) | 2013-02-08 | 2014-02-07 | Reduced sodium food products |
ES20175617T Active ES2936634T3 (en) | 2013-02-08 | 2014-02-07 | Reduced Sodium Food Products |
ES14705944.8T Active ES2671954T3 (en) | 2013-02-08 | 2014-02-07 | Sodium Reduced Food Products |
ES14705945.5T Active ES2675018T3 (en) | 2013-02-08 | 2014-02-07 | Sodium Reduced Food Products |
ES14705458T Active ES2704880T3 (en) | 2013-02-08 | 2014-02-07 | Food products reduced in sodium |
ES14705459.7T Active ES2675215T3 (en) | 2013-02-08 | 2014-02-07 | Sodium Reduced Food Products |
Family Applications Before (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES18201716T Active ES2925071T3 (en) | 2013-02-08 | 2014-02-07 | Reduced sodium food products |
ES18164825T Active ES2831028T3 (en) | 2013-02-08 | 2014-02-07 | Reduced sodium food products |
ES20175617T Active ES2936634T3 (en) | 2013-02-08 | 2014-02-07 | Reduced Sodium Food Products |
ES14705944.8T Active ES2671954T3 (en) | 2013-02-08 | 2014-02-07 | Sodium Reduced Food Products |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES14705458T Active ES2704880T3 (en) | 2013-02-08 | 2014-02-07 | Food products reduced in sodium |
ES14705459.7T Active ES2675215T3 (en) | 2013-02-08 | 2014-02-07 | Sodium Reduced Food Products |
Country Status (11)
Country | Link |
---|---|
US (4) | US11540539B2 (en) |
EP (7) | EP3732994B1 (en) |
JP (6) | JP2016509830A (en) |
CN (4) | CN105189460B (en) |
BR (2) | BR112015018847A2 (en) |
CA (3) | CA2900710C (en) |
DK (7) | DK3366677T3 (en) |
ES (7) | ES2925071T3 (en) |
FI (1) | FI3732994T3 (en) |
PT (7) | PT2954037T (en) |
WO (13) | WO2014124222A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014124222A1 (en) | 2013-02-08 | 2014-08-14 | General Mills, Inc. | Reduced sodium food products |
CN105384721A (en) * | 2015-12-07 | 2016-03-09 | 西宁意格知识产权咨询服务有限公司 | Novel biphenyl cyclooctene lignin compound, and preparation method and application thereof |
US11078157B1 (en) | 2018-01-31 | 2021-08-03 | University Of Oregon | Compound embodiments that release H2S by reaction with a reactive compound and methods of making and using the same |
US11040942B1 (en) | 2018-01-31 | 2021-06-22 | University Of Oregon | Compound embodiments for hydrogen sulfide production and methods of making and using the same |
US11700869B2 (en) * | 2018-06-27 | 2023-07-18 | Pepsico, Inc. | Mouthfeel enhancing composition |
EP3756474B1 (en) | 2019-06-25 | 2024-03-06 | Analyticon Discovery GmbH | An extract of persea |
US20220273011A1 (en) * | 2019-11-11 | 2022-09-01 | Firmenich Sa | Gingerol compounds and their use as flavor modifiers |
EP4048086A1 (en) * | 2020-03-05 | 2022-08-31 | Firmenich SA | 11-oxo-cucurbitanes and their use as flavor modifiers |
US20220218007A1 (en) * | 2021-01-14 | 2022-07-14 | Raghavi Kantharuban | Methods and composition to reduce salt in food products |
US20220248732A1 (en) * | 2021-02-05 | 2022-08-11 | Frito-Lay North America, Inc. | Saltiness-Perception Enhancing Compounds |
EP4277474A1 (en) * | 2021-04-06 | 2023-11-22 | Firmenich SA | Use of gingerdiol compounds to enhance flavor |
CN113582981B (en) * | 2021-07-08 | 2023-09-05 | 中国科学院昆明植物研究所 | Novel diaryl heptane-flavanone hybrid, and pharmaceutical composition and application thereof |
Family Cites Families (291)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4160862A (en) | 1972-06-12 | 1979-07-10 | Sterling Drug Inc. | 1-Acyl-3-(amino-lower-alkyl)indoles |
JPS5810429A (en) | 1981-07-07 | 1983-01-21 | Inoue Japax Res Inc | Wire cut discharge processing method |
JPS58212764A (en) * | 1982-06-03 | 1983-12-10 | Sadao Nakayama | Seasoning compositions and food using them |
HU194220B (en) | 1985-04-19 | 1988-01-28 | Richter Gedeon Vegyeszet | Process for production of derivatives of 1,12 b disubstituated-octahydro-indolo /2,3-a/ quinolisine and medical compounds containing thereof |
US4997672A (en) * | 1987-03-10 | 1991-03-05 | Virginia Commonwealth University | Salt taste enhancer |
DE3924607A1 (en) | 1989-07-21 | 1991-01-24 | Singer Peter Dr Sc Med | Diet food contg. omega-3-fatty acid, omega-6-fatty acid - with sodium ions and potassium ions, reducing risk of heart and circulation disease |
JPH03161470A (en) | 1989-11-17 | 1991-07-11 | Nisshin Flour Milling Co Ltd | Indole derivative |
US5232684A (en) | 1990-06-29 | 1993-08-03 | The United States Of America As Represented By The Department Of Health And Human Services | Labelled resiniferatoxin, compositions thereof, and methods for using the same |
US5874479A (en) | 1991-03-01 | 1999-02-23 | Warner-Lambert Company | Therapeutic permeation enhanced-wound healing compositions and methods for preparing and using same |
DE4217842A1 (en) | 1992-05-29 | 1993-12-02 | Dietl Hans | Pharmaceutical compsns. for intravenous or intra-coronary admin. - are aq. emulsions contg. 1,4-di:hydro:pyridine calcium antagonist, natural oil and phosphatidyl-choline or phosphatidyl-ethanolamine |
US5260091A (en) * | 1992-10-21 | 1993-11-09 | Interneuron Pharmaceuticals Inc. | Salt taste enhancers |
US5620989A (en) | 1992-10-28 | 1997-04-15 | Merck Sharp & Dohme Limited | 4-Arylmethyloxymethyl piperidines as tachykinin antagonsits |
DK0680470T3 (en) | 1993-01-21 | 1997-04-28 | Merrell Pharma Inc | |
US5719148A (en) | 1993-10-15 | 1998-02-17 | Schering Corporation | Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
JP3014575B2 (en) | 1993-10-29 | 2000-02-28 | 寳酒造株式会社 | Taste improver |
US5494919A (en) | 1993-11-09 | 1996-02-27 | Merck & Co., Inc. | 2-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
JP3575705B2 (en) | 1994-08-02 | 2004-10-13 | 小川香料株式会社 | Method for producing gingerol and shogaol |
EP0804434A1 (en) | 1994-08-02 | 1997-11-05 | MERCK SHARP & DOHME LTD. | Azetidine, pyrrolidine and piperidine derivatives |
US5919614A (en) | 1994-10-19 | 1999-07-06 | Lifecell Corporation | Composition comprising three platelet lesion inhibitors for platelet storage |
US6221669B1 (en) | 1994-10-19 | 2001-04-24 | Lifecell Corporation | Prolonged preservation of blood platelets |
CA2207201A1 (en) | 1994-12-06 | 1996-06-13 | Caroline Henry | Azetidine, pyrrolidine and piperidine derivatives as 5ht1 receptor agonists |
US5700806A (en) | 1995-03-24 | 1997-12-23 | Schering Corporation | Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
TW453881B (en) | 1995-10-16 | 2001-09-11 | Kao Corp | Cosmetic composition comprising amide derivatives |
NZ321575A (en) | 1995-10-30 | 1999-05-28 | Janssen Pharmaceutica Nv | 1-(1,2-disubstituted piperidinyl)-4- substituted piperazine derivatives |
GB9523243D0 (en) | 1995-11-14 | 1996-01-17 | Merck Sharp & Dohme | Therapeutic agents |
TW429256B (en) | 1995-12-27 | 2001-04-11 | Janssen Pharmaceutica Nv | 1-(1,2-disubstituted piperidinyl)-4-(benzimidazolyl- and imidazopyridinyl)-piperidine derivatives |
JP3549366B2 (en) | 1996-06-20 | 2004-08-04 | 株式会社林原生物化学研究所 | Method for enhancing taste and / or umami from salt in food and drink |
DE69834038D1 (en) | 1997-07-01 | 2006-05-18 | Isis Pharmaceutical Inc | COMPOSITIONS AND METHOD FOR THE ADMINISTRATION OF OLIGONUCLEOTIDES OVER THE DISHES |
GB9807607D0 (en) | 1998-04-08 | 1998-06-10 | Bp Chem Int Ltd | Fuel additive |
US6303620B1 (en) | 1998-05-11 | 2001-10-16 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
US6841539B1 (en) | 1998-05-21 | 2005-01-11 | Isis Pharmaceuticals, Inc. | Compositions and methods for topical delivery of oligonucleotides |
AU745880B2 (en) | 1998-05-21 | 2002-04-11 | Isis Pharmaceuticals, Inc. | Compositions and methods for non-parenteral delivery of oligonucleotides |
US5948460A (en) | 1998-07-27 | 1999-09-07 | Takasago International Corporation | Flavored product additive and method for using same |
JP4267783B2 (en) | 1998-10-02 | 2009-05-27 | 株式会社インテリジェントセンサーテクノロジー | Taste recognition device |
AU3515700A (en) | 1999-03-10 | 2000-09-28 | Axys Pharmaceuticals, Inc. | Process for the synthesis of dihydropyridones |
US6309663B1 (en) | 1999-08-17 | 2001-10-30 | Lipocine Inc. | Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
RU2164766C1 (en) * | 1999-10-22 | 2001-04-10 | Емец Юрий Алексеевич | Food biologically active addition |
DE60102402T2 (en) | 2000-02-10 | 2005-03-10 | Loders Croklaan B.V. | Fat blends with crystal modifiers |
GB0003397D0 (en) | 2000-02-14 | 2000-04-05 | Merck Sharp & Dohme | Therapeutic agents |
JP3394737B2 (en) | 2000-03-03 | 2003-04-07 | 正田醤油株式会社 | Low salt soy sauce seasoning |
DE20008343U1 (en) | 2000-05-09 | 2000-09-14 | Abatu Fuat | Spice mix |
DE60114708T2 (en) | 2000-06-05 | 2006-07-20 | Loders Croklaan B.V. | Ursolic acid and oleanolic acid containing mixtures |
GB0023918D0 (en) * | 2000-09-29 | 2000-11-15 | King S College London | Antiparasitic compounds |
JP2002125616A (en) | 2000-10-27 | 2002-05-08 | Apio Club:Kk | Method for producing herb salt |
US20120237626A9 (en) | 2000-12-05 | 2012-09-20 | Palu Afa Kehaati | Profiles of lipid proteins and inhibiting HMG-CoA reductase |
JP4277294B2 (en) | 2000-12-26 | 2009-06-10 | 佐藤食品工業株式会社 | Method for improving the flavor of food |
WO2002080904A1 (en) * | 2001-04-05 | 2002-10-17 | Kyowa Hakko Kogyo Co., Ltd. | Liver funcion protecting or ameliorating agent |
AU772384B2 (en) * | 2001-05-09 | 2004-04-29 | Nestec S.A. | Vitex agnus castus extract |
JP2002345430A (en) | 2001-05-28 | 2002-12-03 | Kyowa Hakko Kogyo Co Ltd | Method for enhancing salt taste, salt taste enhancer, salt taste seasoning, and salt taste-enhanced food and beverage |
JP2002370922A (en) | 2001-06-15 | 2002-12-24 | Azuma Noen:Kk | Cosmetic containing japanese plum extract |
WO2003008632A1 (en) | 2001-07-16 | 2003-01-30 | Hoegestaett Edward | Fatty acid conjugation as a method for screening of potentially bioactive substances |
WO2003018549A2 (en) | 2001-08-30 | 2003-03-06 | Chemocentryx, Inc. | Bicyclic compounds as inhibitors of chemokine binding to us28 |
JP4278896B2 (en) | 2001-11-02 | 2009-06-17 | 丸善製薬株式会社 | Hihatsu fruit extract composition, food and drink containing Hihatsu fruit extract, and method for improving taste of Hihatsu fruit extract |
CN1347664A (en) | 2001-11-07 | 2002-05-08 | 林泽垠 | Natural non-salt salty food additive and its prepn |
US6743461B1 (en) * | 2001-11-09 | 2004-06-01 | Ecosalt Corporation | Salt substitute compositions |
CN1435123A (en) | 2002-02-01 | 2003-08-13 | 冯旭斌 | Rolled chilli |
WO2003075929A1 (en) | 2002-03-13 | 2003-09-18 | Janssen Pharmaceutica N.V. | Inhibitors of histone deacetylase |
US6929809B2 (en) | 2002-03-26 | 2005-08-16 | Council Of Scientific And Industrial Research | Preparation of nutrient rich salt of plant origin |
US6691780B2 (en) | 2002-04-18 | 2004-02-17 | Halliburton Energy Services, Inc. | Tracking of particulate flowback in subterranean wells |
WO2003092676A1 (en) | 2002-04-29 | 2003-11-13 | The General Hospital Corporation | Compositions and methods for preventing abuse of orally administered medications |
MY141736A (en) | 2002-10-08 | 2010-06-15 | Elanco Animal Health Ireland | Substituted 1,4-di-piperidin-4-yi-piperazine derivatives and their use as neurokinin antagonists |
US20100173993A1 (en) | 2003-02-06 | 2010-07-08 | Sawyer Anthony J | Controlled release biocidal salts |
GB0306399D0 (en) | 2003-03-20 | 2003-04-23 | Ineos Fluor Holdings Ltd | Process for reducing the concentration of undesired compounds in a composition |
US20040202735A1 (en) | 2003-04-08 | 2004-10-14 | Moore Bob M. | Method and kit for controlling bleeding |
ES2307025T3 (en) | 2003-06-10 | 2008-11-16 | Janssen Pharmaceutica Nv | COMBINATION OF OPIOIDES AND A DERIVATIVE OF PIPERAZINE FOR THE TREATMENT OF PAIN. |
US20060128721A1 (en) | 2003-06-10 | 2006-06-15 | Janssens Frans E | Novel formulations of opioid-based treatments of pain comprising substituted 1,4-di-piperidin-4-yl-piperazine derivatives |
US20080060576A1 (en) | 2003-06-27 | 2008-03-13 | Sumitomo Electric Industries, Ltd. | Wafer Holder for Semiconductor Manufacturing Device and Semiconductor Manufacturing Device in Which It Is Installed |
JP2005013138A (en) | 2003-06-27 | 2005-01-20 | Kiyomitsu Kawasaki | Method for producing spice flavor |
JP2005015684A (en) | 2003-06-27 | 2005-01-20 | Kiyomitsu Kawasaki | Method for preparing vegetable flavor |
US20050031717A1 (en) | 2003-07-09 | 2005-02-10 | Desimone John A. | Salt taste modification |
RU2363259C2 (en) | 2003-07-10 | 2009-08-10 | Такасаго Интернешнл Корпорейшн | Taste intensifying agent, food products ot beverages containing taste intensifying agent and taste intensifying method |
US20050025844A1 (en) | 2003-08-02 | 2005-02-03 | Matthias Boldt | Weight control compositions and methods |
US7846422B2 (en) | 2003-08-04 | 2010-12-07 | Kao Corporation | Method for prevention or treatment of periodontal diseases and composition for an oral cavity |
NL1026826C2 (en) | 2003-08-13 | 2007-01-04 | Pharmacia Corp | Substituted pyridinones. |
ES2481167T3 (en) | 2003-08-22 | 2014-07-29 | Dupont Nutrition Biosciences Aps | Composition comprising a bacteriocin and an extract from a plant of the Labiatae family |
GB2388581A (en) | 2003-08-22 | 2003-11-19 | Danisco | Coated aqueous beads |
JP2005075785A (en) | 2003-09-01 | 2005-03-24 | Japan Science & Technology Agency | Piperidine derivative and method for producing the same |
US20070093552A1 (en) | 2003-09-22 | 2007-04-26 | Futoshi Matsuyama | Early insulin secretion stimulator |
US20070059351A1 (en) | 2003-10-17 | 2007-03-15 | Murrell George A C | Transdermal patches containing a nitric oxide-donor and a second active agent and associated methods |
CN100391364C (en) * | 2003-10-30 | 2008-06-04 | 张湘生 | Flavouring spicery |
TWI356681B (en) | 2003-11-12 | 2012-01-21 | J Oil Mills Inc | Body taste improver comprising long-chain highly u |
US8389031B2 (en) | 2005-05-23 | 2013-03-05 | Kraft Foods Global Brands Llc | Coated delivery system for active components as part of an edible composition |
JP2007514727A (en) | 2003-12-19 | 2007-06-07 | リピッド ニュートリション ベスローテン フェンノートシャップ | Use of a composition comprising oleanolic acid and ursolic acid for the preparation of a medicament for the treatment of hypersensitivity and hyperreactivity |
CA2556589A1 (en) | 2004-02-24 | 2005-09-01 | Bioaxone Therapeutique Inc. | 4-substituted piperidine derivatives |
US20050215635A1 (en) * | 2004-03-08 | 2005-09-29 | Rafi M Mohamed | Diarylheptanoid compounds and uses thereof |
WO2005097261A1 (en) | 2004-03-30 | 2005-10-20 | Sapphire Therapeutics, Inc. | Method of reducing c-reactive protein using growth hormone secretagogues |
JP2005298449A (en) | 2004-04-15 | 2005-10-27 | Astellas Pharma Inc | 4-aminopyrimidine derivative |
EP1763349A2 (en) | 2004-06-03 | 2007-03-21 | Jonathan J. Burbaum | Pharmaceutical compositions for the treatment of pruritus |
KR20050122373A (en) | 2004-06-24 | 2005-12-29 | 대한민국(서울대학교 총장) | Composition comprising a root extract of salvia miltiorrhiza or dimethyl lithospermate b as a sodium channel agonist |
JP4993407B2 (en) | 2004-08-04 | 2012-08-08 | 大正製薬株式会社 | Triazole derivative |
DE102004038396A1 (en) | 2004-08-06 | 2006-03-30 | Lothar Sellin | Device (I), for coating medicinal products, comprises equipment for producing ultrasound and a vacuum chamber containing retaining means for one or more medicinal products |
PL1786272T3 (en) | 2004-08-11 | 2015-02-27 | Intercontinental Great Brands Llc | Warming compositions and delivery systems therefor |
ES2388501T3 (en) | 2004-08-12 | 2012-10-16 | Helsinn Healthcare S.A. | Use of growth hormone secretagogues to stimulate the motility of the gastrointestinal system |
EP1789090A2 (en) | 2004-09-02 | 2007-05-30 | Bionaut Pharmaceuticals, Inc. | Combinatorial chemotherapy treatment using na+/k+-atpase inhibitors |
GB0420722D0 (en) | 2004-09-17 | 2004-10-20 | Addex Pharmaceuticals Sa | Novel allosteric modulators |
CA2582324A1 (en) | 2004-10-01 | 2006-04-13 | Merck & Co., Inc. | Compositions and methods for treating ophthalmic diseases |
WO2006044916A2 (en) | 2004-10-18 | 2006-04-27 | Bionaut Pharmaceuticals, Inc. | Use of na+/ k+-atpase inhibitors and antagonists thereof |
JP2006124322A (en) | 2004-10-28 | 2006-05-18 | Takasago Internatl Corp | Hyaluronidase inhibitor, skin care composition for external use containing the hyaluronidase inhibitor, and oral composition containing the same |
US20080103202A1 (en) | 2004-11-08 | 2008-05-01 | Chris Ferguson | Method of preparing creatine ester salts and uses thereof. |
CA2589260A1 (en) * | 2004-11-29 | 2006-06-01 | Aloecorp, Inc. | Dehydration of food combinations |
US20080268092A1 (en) | 2004-12-01 | 2008-10-30 | Dacanay Rhodel G | Capsaicin Nutritional Supplement |
JP4942141B2 (en) | 2004-12-02 | 2012-05-30 | 江崎グリコ株式会社 | Glucose transfer method to carboxyl group |
JP2008524267A (en) | 2004-12-22 | 2008-07-10 | メステックス アクチェンゲゼルシャフト | Mixtures of vanilloid receptor agonists and nerve regeneration substance inhibitors, their use to produce analgesics, and methods of applying the analgesics |
ATE549018T1 (en) | 2004-12-28 | 2012-03-15 | Mestex Ag | USE OF A VANILLOID RECEPTOR AGONIST TOGETHER WITH A GLYCOSAMINOGLYCAN OR PROTEOGLYCAN FOR THE PRODUCTION OF AN AGENT FOR THE TREATMENT OF JOINT PAIN AND METHOD OF APPLYING SUCH AGENT |
NZ556261A (en) | 2005-01-28 | 2012-04-27 | Adm Alliance Nutrition Inc | Animal feed compositions capable of reducing the incidence of fescue toxicosis in mammas containing a coated or encapsulated capsaicin product and an adsorbant |
DE602005002728T2 (en) | 2005-02-18 | 2008-07-24 | The Procter & Gamble Company, Cincinnati | Caffeine-containing confectionery |
US20060198806A1 (en) | 2005-03-04 | 2006-09-07 | Reilly Christopher A | Capsaicinoid decontamination compositions and methods of use |
JP2006238814A (en) | 2005-03-04 | 2006-09-14 | Ogawa & Co Ltd | Flavor enhancing agent, seasoning, food and drink containing the enhancing agent and the seasoning, and flavor enhancing method |
EP1859035B1 (en) | 2005-03-08 | 2016-01-13 | Agency for Science, Technology and Research | Immobilised enzymes |
US20060204601A1 (en) | 2005-03-09 | 2006-09-14 | Palu Afa K | Formulations and methods for preventing and treating substance abuse and addiction |
JP2006246857A (en) | 2005-03-14 | 2006-09-21 | Showa Sangyo Co Ltd | Oil and fat composition, and food |
WO2006107832A2 (en) | 2005-04-05 | 2006-10-12 | President And Fellows Of Harvard College | Methods and kits for isolating nucleic acids |
JP4508932B2 (en) | 2005-04-25 | 2010-07-21 | 小川香料株式会社 | Taste enhancer, flavor containing the taste enhancer, and food and drink containing the flavor |
MX349340B (en) | 2005-05-23 | 2017-07-24 | Intercontinental Great Brands Llc | Taste potentiator compositions and beverages containing same. |
CN1736485A (en) | 2005-06-29 | 2006-02-22 | 上海美迪西生物医药有限公司 | Use of vanillin receptor agonist in preparation of product for resisting Alzheimer disease |
WO2007018514A1 (en) | 2005-07-28 | 2007-02-15 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
WO2007018508A1 (en) | 2005-07-28 | 2007-02-15 | Glaxo Group Limited | Novel m3 muscarinic acetycholine receptor antagonists |
GB0520845D0 (en) | 2005-10-14 | 2005-11-23 | Hofmann Thomas F | Salt enhancing compounds and use |
US9125833B2 (en) | 2005-11-02 | 2015-09-08 | Relmada Therapeutics, Inc. | Multimodal abuse resistant and extended release opioid formulations |
US20070184137A1 (en) | 2005-11-29 | 2007-08-09 | Palu Afa K | Morinda Citrifolia L. Based Formulations for Inhibiting Matrix Metalloproteinase Enzymes |
CN100490870C (en) | 2006-01-13 | 2009-05-27 | 东莞广发制药有限公司 | Spleen and kidney invigorating preparation and its preparing process and inspection method |
JP5218737B2 (en) | 2006-02-06 | 2013-06-26 | 大正製薬株式会社 | Sphingosine-1-phosphate binding inhibitor |
JP2007232574A (en) | 2006-03-01 | 2007-09-13 | Ajinomoto Co Inc | Screening method of sympathetic nerve activator |
CN1820646A (en) | 2006-03-11 | 2006-08-23 | 刘仁虎 | Health food containing paederia scandens |
CN1857586A (en) | 2006-03-28 | 2006-11-08 | 石圣洪 | Osteoporsis treating Chinese medicine preparation and its preparing process |
CN1857343A (en) | 2006-04-11 | 2006-11-08 | 徐蕾 | Chinese medicine composition for preventing and treating viral cold and throat disease and its preparing method |
CA2544227A1 (en) | 2006-04-20 | 2007-10-20 | Metabev Inc. | Food product containing policosanols |
US20070248621A1 (en) | 2006-04-24 | 2007-10-25 | Metabev Llc | Food product containing policosanols |
US9789161B2 (en) | 2006-04-28 | 2017-10-17 | Warsaw Orthopedic, Inc. | Methods for treating back or neck pain caused by NGF using a therapeutic agent consisting of ReN-1820, ALE-0540 and capsaicin |
US8916611B2 (en) | 2006-04-28 | 2014-12-23 | Warsaw Orthopedic, Inc. | Pharmaceutical removal of neuronal extensions from a degenerating disc |
US20070287991A1 (en) | 2006-06-08 | 2007-12-13 | Mckay William F | Devices and methods for detection of markers of axial pain with or without radiculopathy |
JP2008000005A (en) * | 2006-06-20 | 2008-01-10 | Shizuoka Prefecture | Agent for ameliorating dysphagia and food for ameliorating dysphagia |
JP5265142B2 (en) * | 2006-06-21 | 2013-08-14 | 株式会社Adeka | Salt composition containing salty taste enhancer |
CN101095800A (en) | 2006-06-29 | 2008-01-02 | 朱靖华 | Development of paster for treating mouth ulcer |
WO2008011083A2 (en) | 2006-07-18 | 2008-01-24 | Cornell Research Foundation, Inc. | Compounds for enhancing arginase activity and methods of use thereof |
WO2008021394A2 (en) | 2006-08-15 | 2008-02-21 | Theraquest Biosciences, Llc | Pharmaceutical formulations of cannabinoids and method of use |
WO2008024490A2 (en) | 2006-08-24 | 2008-02-28 | Theraquest Biosciences, Inc. | Oral pharmaceutical formulations of abuse deterrent cannabinoids and method of use |
WO2008027442A2 (en) | 2006-08-30 | 2008-03-06 | Theraquest Biosciences, Llc | Abuse deterrent oral pharmaceutical formulations of opioid agonists and method of use |
WO2008033351A2 (en) | 2006-09-11 | 2008-03-20 | Theraquest Biosciences, Inc. | Multimodal abuse resistant and extended release formulations |
BRPI0715257B1 (en) | 2006-10-04 | 2023-03-07 | Unilever N.V | FRACTIONED TOMATO EXTRACT, FLAVOR ENHANCEMENT COMPOSITION, USE OF A FRACTIONED TOMATO EXTRACT, METHOD OF PRODUCTION OF A FRACTIONED TOMATO EXTRACT, METHOD OF PREPARATION OF A PRODUCT AND PRODUCT |
CA2606658A1 (en) | 2006-10-13 | 2008-04-13 | Mike Tyers | Compositions and methods for treating neurological disorders or damage |
US20080124753A1 (en) | 2006-11-15 | 2008-05-29 | Lee Seunghun Paul | SpiceMatrix Technology for Taste Compound Identification |
WO2008063603A2 (en) | 2006-11-20 | 2008-05-29 | President And Fellows Of Harvard College | Methods, compositions, and kits for treating pain and pruritis |
US20100068221A1 (en) | 2006-12-07 | 2010-03-18 | Arie Gerrit Terdu | Low salt food with improved taste |
CA2671190A1 (en) | 2006-12-07 | 2008-06-12 | Dsm Ip Assets B.V. | Low salt food with improved taste |
US20090312255A1 (en) | 2006-12-14 | 2009-12-17 | The Hospital For Sick Children | Stimulation of trpv1+ sensory neurons to control beta-cell stress and islet inflammation in diabetes |
CN101562986A (en) * | 2006-12-19 | 2009-10-21 | 帝斯曼知识产权资产管理有限公司 | Reduced-salt dairy product with improved taste |
EA200970764A1 (en) | 2007-02-13 | 2010-04-30 | ХЕЛСИНН ТЕРАПЬЮТИКС (Ю. Эс.), ИНК. | METHOD OF TREATMENT OF DISORDERS CAUSED BY PROLIFERATION OF CELLS WITH THE USE OF STIMULATORS OF THE GROWTH HORMONE SECRETION |
WO2008100977A2 (en) | 2007-02-14 | 2008-08-21 | N.V. Organon | Carbamates therapeutic release agents as amidase inhibitors |
US20080199595A1 (en) * | 2007-02-15 | 2008-08-21 | Mccormick & Company | Salt replacing composition, process for its preparation and food systems containing such composition |
BRPI0808150A2 (en) | 2007-02-28 | 2014-07-01 | Procter & Gamble | METHODS AND TARGETS FOR IDENTIFYING COMPOUNDS FOR REGULATING RHINOVIRUS INFECTION |
RU2462048C2 (en) | 2007-03-22 | 2012-09-27 | Экосолт Корпорэйшн | Non-bitter composition containing no sodium or with low sodium salt content |
US20130115320A1 (en) | 2007-03-30 | 2013-05-09 | Dynova Laboratories, Inc. | Therapeutic agent for intranasal administration and method of making and using same |
US20130115321A1 (en) | 2007-03-30 | 2013-05-09 | Dynova Laboratories, Inc. | Therapeutic agent for intranasal administration and method of making and using same |
US20080241117A1 (en) | 2007-04-02 | 2008-10-02 | Abdul Gaffar | Oral Care Compositions Containing a Mixed Tocopherol Component |
US20100080867A1 (en) | 2007-04-05 | 2010-04-01 | Givaudan Sa | Fermented Ingredient |
US8507027B2 (en) | 2007-04-09 | 2013-08-13 | Japan Tobacco Inc. | Seasoning compositions, salt-like taste enhancer and method for enhancing salt-like taste of food and drink |
TWI429436B (en) | 2007-04-10 | 2014-03-11 | Helsinn Therapeutics Us Inc | Methods of treating or preventing emesis using growth hormone secretagogues |
US20080268001A1 (en) | 2007-04-30 | 2008-10-30 | Lynette Zaidel | Oral care composition to reduce or eliminate dental sensitivity |
US20080267891A1 (en) | 2007-04-30 | 2008-10-30 | Colgate-Palmolive Company | Oral Care Composition To Reduce Or Eliminate Dental Sensitivity |
WO2008139152A1 (en) | 2007-05-11 | 2008-11-20 | Sentinel Oncology Limited | N-oxide-containing pharmaceutical compounds |
KR100784229B1 (en) | 2007-05-17 | 2007-12-11 | 주식회사 파이토코 | Salicornia herbacea-derived salt and its production process |
DE502008002360D1 (en) | 2007-06-19 | 2011-03-03 | Symrise Ag | Aroma composition for reducing or suppressing undesirable bitter and astringent impression |
EP2011495A1 (en) | 2007-07-03 | 2009-01-07 | Sygnis Bioscience GmbH & Co. KG | Use of piperine and derivatives thereof for the therapy of neurological conditions |
KR100891935B1 (en) | 2007-07-10 | 2009-04-08 | 박양순 | The method preparing for a sweet drink made fromfermented rice |
KR100903739B1 (en) | 2007-08-24 | 2009-06-19 | 씨제이제일제당 (주) | Granulated seasoning salt and preparation method thereof |
JP2010538636A (en) * | 2007-09-13 | 2010-12-16 | フイルメニツヒ ソシエテ アノニム | Flavor composition for flavor applications |
EP2042043A1 (en) | 2007-09-26 | 2009-04-01 | Nestec S.A. | A shelf-stable taste enhancing cultured savoury base and a process for its preparation |
US20100311678A1 (en) | 2007-10-04 | 2010-12-09 | Bean Bruce P | Methods and compositions for treating cancer and modulating signal transduction and metabolism pathways |
CL2007002915A1 (en) | 2007-10-10 | 2008-04-25 | Cox Y Compania S A | COMPOSITION FOR FOOD, NUTRITIVE SUPPLEMENTS, NUTRACEUTICAL PRODUCTS OR OTHER HUMAN CONSUMPTION THAT INCLUDES SODIUM CHLORIDE, POTASSIUM CHLORIDE, ACIDS AND SWEETENERS, WHERE THE PROPORTIONS OF SUCH COMPONENTS CONFORM TO THE COMPOSITION |
EP3320921B1 (en) | 2007-11-05 | 2022-01-05 | Ala Wai Pharma, Inc. | Formulations for enhanced bioavailability of orally administered polar agents |
MX2010005465A (en) | 2007-11-19 | 2010-06-02 | Nestec Sa | Treatment of oral pharyngeal dysphagia. |
WO2009071095A2 (en) | 2007-12-05 | 2009-06-11 | Neurokey A/S | Prevention of hyperthermia subsequent to hypothermia treatment of ischemia |
WO2009071096A2 (en) | 2007-12-05 | 2009-06-11 | Neurokey A/S | Combination of medical and physical cooling treatment of ischemic effects |
WO2009071094A2 (en) | 2007-12-05 | 2009-06-11 | Neurokey A/S | Combination treatment of ischemic effects |
CN101254226B (en) | 2007-12-19 | 2011-01-19 | 游洪涛 | Duliang compound chinese medicine soft capsules |
ES2531939T5 (en) | 2007-12-21 | 2019-01-10 | Unilever Nv | Active fractions of umami and methods to prepare them |
CN101214278B (en) | 2007-12-26 | 2012-06-27 | 沈阳药科大学 | New raw material for extracting fructus schizandrae total lignans and preparation technique and use |
US9259006B2 (en) | 2008-01-30 | 2016-02-16 | Smartwash Solutions, Llc | Antimicrobial compositions and methods of use thereof |
US20110052763A1 (en) | 2008-02-24 | 2011-03-03 | Zohar Nir | Use of soluble tomato solids for reducing the salt content of food products |
CA2717042A1 (en) | 2008-03-11 | 2009-09-17 | The General Hospital Corporation | Methods, compositions, and kits for treating pain and pruritis |
BR122017026860B1 (en) | 2008-03-17 | 2020-11-10 | Givaudan Sa | process for forming a salt-enhancing ingredient, flavor composition for food products, food product and method for providing it |
JP5596536B2 (en) | 2008-03-24 | 2014-09-24 | 日本水産株式会社 | Salty taste enhancer and food and drink containing the same |
WO2009124551A2 (en) | 2008-04-09 | 2009-10-15 | Neurokey A/S | Use of hypothermia inducing drugs |
WO2009124552A2 (en) | 2008-04-09 | 2009-10-15 | Neurokey A/S | Use of a combination of hypothermia inducing drugs |
JP2011518844A (en) | 2008-04-25 | 2011-06-30 | ナノバイオ コーポレーション | Nanoemulsions for treating fungal, yeast and filamentous fungal infections |
EP2306845B1 (en) | 2008-06-20 | 2015-02-18 | Givaudan SA | Enzymatic process |
US20110189161A1 (en) | 2008-06-21 | 2011-08-04 | Kenneth Blum | Nutrigenomics methods and compositions |
JP5452893B2 (en) | 2008-06-25 | 2014-03-26 | 小川香料株式会社 | Taste improving agent for potassium salts or foods and drinks containing potassium salts |
US8460657B2 (en) | 2008-06-25 | 2013-06-11 | H. Lundbeck A/S | Modulation of the TrpV: Vps10p receptor system for the treatment of pain |
US8808768B2 (en) | 2008-07-21 | 2014-08-19 | Kailash Chandra Agarwal | Development of biochemically standardized extracts from fresh rhizomes of turmeric (Curcuma longa) for treatment of diseases caused by hyperuricemia |
CN101318985A (en) | 2008-07-23 | 2008-12-10 | 谢佳良 | Preparation method for ursolic acid, produced products and application thereof |
US20100034944A1 (en) | 2008-08-06 | 2010-02-11 | Martha Lubenova Beyazova | Use of Avocado Derivatives in Flavor Applications |
WO2010015260A2 (en) | 2008-08-07 | 2010-02-11 | Neurokey A/S | Administration by infusion for the treatment of ischemic effects |
KR100995839B1 (en) | 2008-08-08 | 2010-11-22 | 주식회사 아이토비 | Multi contents display system and method thereof |
MX2008010606A (en) | 2008-08-18 | 2010-02-17 | Integradora Bravo S A De C V | Phytosanitary compositions enhanced with raw vegetable oils and derivatives thereof, and the use thereof for the plague control. |
US8143259B2 (en) | 2008-08-19 | 2012-03-27 | Janssen Pharmaceutica, Nv | Cold menthol receptor antagonists |
WO2010026596A2 (en) * | 2008-09-08 | 2010-03-11 | Shai Meretzki | Compositions comprising polyhydroxyltate fatty alcohol derivatives and the therapeutic uses |
AU2008221548A1 (en) | 2008-09-19 | 2010-04-08 | Greentaste Pty Ltd | Method For and Composition of Excipient Suitable for Use in Herbal Formulations and Formulations Derived Therefrom |
WO2010036878A1 (en) | 2008-09-26 | 2010-04-01 | The Trustees Of Columbia University In The City Of New York | Use of trpv1 receptor agonists in cervical pain and labor |
US20100099766A1 (en) | 2008-10-16 | 2010-04-22 | Novartis Ag | Topical NSAID compositions having sensate component |
US20110237674A1 (en) | 2008-10-16 | 2011-09-29 | Novartis Ag | Topical nsaid compositions having sensate component |
JP2010094081A (en) | 2008-10-17 | 2010-04-30 | Kao Corp | Food and drink composition |
JP5376629B2 (en) | 2008-10-24 | 2013-12-25 | 長谷川香料株式会社 | Flavor degradation inhibitor |
JP5159568B2 (en) | 2008-11-07 | 2013-03-06 | 小林製薬株式会社 | Food / beverage composition containing hihatsu extract and method for improving taste of food / beverage composition containing hihatsu extract |
US8709391B2 (en) | 2008-11-26 | 2014-04-29 | Board Of Regents Of The University Of Texas System | Family of pain producing substances and methods to produce novel analgesic drugs |
WO2010078392A2 (en) | 2008-12-31 | 2010-07-08 | Novozymes North America, Inc. | Processes of producing fermentation products |
WO2010092467A1 (en) | 2009-02-13 | 2010-08-19 | Carlo Ghisalberti | Medicament comprising terpenoid cholinesterase inhibitor for treatment of dismotility disorder |
CN102340999B (en) * | 2009-03-16 | 2013-10-30 | 麒麟协和食品株式会社 | Agent for enhancing taste of common salt |
WO2010108542A1 (en) | 2009-03-25 | 2010-09-30 | Nestec S.A. | A natural taste enhancing savoury base and a process for its preparation |
KR20100109207A (en) | 2009-03-31 | 2010-10-08 | 충남대학교산학협력단 | A method for feeding animal using by the dried powder of epimedium koreanum nakai or the extract thereof showing anti-oxidative activity |
KR100987236B1 (en) | 2009-03-31 | 2010-10-12 | 충남대학교산학협력단 | Composition comprising the dried powder of epimedium koreanum nakai or the extract thereof showing anti-oxidative activity |
KR101676375B1 (en) | 2009-04-09 | 2016-11-15 | 시므라이즈 아게 | Compositions comprising trans-tert-butyl cyclohexanol as skin irritation-reducing agent |
CN101862312A (en) | 2009-04-14 | 2010-10-20 | 中国中医科学院中药研究所 | New application of 6-gingerol |
US8962057B2 (en) | 2009-04-29 | 2015-02-24 | The Procter & Gamble Company | Methods for improving taste and oral care compositions with improved taste |
CN105285906A (en) * | 2009-04-29 | 2016-02-03 | 阿克佐诺贝尔化学国际公司 | Process to prepare a low-sodium salt product, product obtainable thereby and the use thereof |
CA2761156C (en) | 2009-05-07 | 2017-03-14 | University Of Cincinnati | Methods of preventing ischemic injury using peripheral nociceptive stimulation |
EP2253226B1 (en) | 2009-05-15 | 2015-07-15 | Leibniz-Institut für Pflanzenbiochemie (IPB) | Use of hydroxyflavone derivatives for modifying taste |
JP5593641B2 (en) * | 2009-06-26 | 2014-09-24 | 味の素株式会社 | Low salt food and beverage composition |
KR101140156B1 (en) | 2009-07-02 | 2012-05-02 | (주)죽력원 | Method for manufacturing functional salt using mulberry leaves |
JP2011030562A (en) | 2009-07-07 | 2011-02-17 | Seinan Jidosha Kogyo Kk | Method for inducing masculinization of gonad of fishes by stress-induced stimulation |
CA2767646C (en) | 2009-07-10 | 2019-01-29 | President And Fellows Of Harvard College | Permanently charged sodium and calcium channel blockers as anti-inflammatory agents |
DE102009027744A1 (en) | 2009-07-15 | 2011-01-20 | Deutsches Institut Für Ernährungsforschung Potsdam-Rehbrücke | Precursor compounds of sweet receptor antagonists for the prevention or treatment of diseases |
KR101181216B1 (en) | 2009-07-29 | 2012-09-07 | 한국생명공학연구원 | Pharmaceutical composition comprising extract or fraction from Evodia fructus or quinolone alkaloid compounds |
JP4845067B2 (en) | 2009-09-01 | 2011-12-28 | 国立大学法人奈良女子大学 | Salty taste enhancer and salty taste enhancing method |
CN102021106B (en) | 2009-09-18 | 2012-11-21 | 劲牌有限公司 | Traditional Chinese medicine health wine and production technology thereof |
US20120201945A1 (en) | 2009-10-02 | 2012-08-09 | House Foods Corporation | Food composition with reinforced or enhanced salty taste and composition containing potassium chloride with suppressed offensive taste |
CN101696377B (en) | 2009-11-04 | 2012-10-31 | 天津市亚天商贸有限公司 | Method for preparing hawthorn dry red wine |
EP2509444A2 (en) | 2009-11-26 | 2012-10-17 | D.Xign | Appetite regulating dietary supplement |
JP5639758B2 (en) | 2009-12-22 | 2014-12-10 | 小川香料株式会社 | Taste improving agent for potassium salts or foods and drinks containing potassium salts |
AU2011212938B2 (en) * | 2010-02-04 | 2015-07-30 | Monell Chemical Senses Center | Compounds and methods for enhancing salty taste |
CA2792878C (en) | 2010-03-12 | 2019-10-22 | Government Of The Usa, As Represented By The Sec., Dept. Of Health And Human Services | Agonist/antagonist compositions and methods of use |
EP2547322A2 (en) | 2010-03-15 | 2013-01-23 | Ulrich Dietz | Use of nitrocarboxylic acids for the treatment, diagnosis and prophylaxis of aggressive healing patterns |
BR112012024159A2 (en) | 2010-03-23 | 2019-09-24 | Walters Jeffrey | texture and taste enhancer and use in food preparation. |
JP5869229B2 (en) | 2010-04-08 | 2016-02-24 | 高砂香料工業株式会社 | Salt enhancer and kelp extract containing the same |
CN102210441A (en) | 2010-04-12 | 2011-10-12 | 王晓鹏 | Technology for making edible fresh salty taste flavoring agent |
US8053007B2 (en) * | 2010-04-13 | 2011-11-08 | Mark Innocenzi | Compositions and methods for fortifying a base food to contain the complete nutritional value of a standard equivalent unit of the nutritional value of one serving of fruits and vegetables (“SFV”) for human consumption |
RU2596989C2 (en) * | 2010-04-15 | 2016-09-10 | Крафт Фудс Груп Брэндс Ллс | Compounds, compositions and methods for reducing or eliminating bitter taste |
JP5733737B2 (en) | 2010-06-11 | 2015-06-10 | 長谷川香料株式会社 | Salty taste enhancer composition |
KR100987630B1 (en) | 2010-07-01 | 2010-10-13 | 주식회사 아이씨푸드 | Substitute product of table salt |
KR101224873B1 (en) | 2010-07-12 | 2013-01-22 | 한국식품연구원 | Making method of fermented ginger |
WO2012015882A1 (en) | 2010-07-27 | 2012-02-02 | Bean Bruce P | Methods and compositions for preventing and relieving muscle cramps and for recovery from neuromuscular irritability and fatigue following exercise |
JP2012025719A (en) | 2010-07-28 | 2012-02-09 | Morinaga Milk Ind Co Ltd | Proton pump inhibiting agent |
US20120034368A1 (en) | 2010-08-06 | 2012-02-09 | Matsutani Chemical Industry Co., Ltd. | Method for improving salty taste of food or beverage and salty taste improving agent |
WO2012035032A2 (en) | 2010-09-13 | 2012-03-22 | Givaudan Sa | Taste enhancement |
CN102396758A (en) | 2010-09-13 | 2012-04-04 | 李全能 | Beverage having multiple health-care functions |
CN101949904A (en) | 2010-09-22 | 2011-01-19 | 中国烟草总公司郑州烟草研究院 | Method for determining content of imperatorin in perfume material angelica officinalis tincture for cigarettes |
US20140088056A1 (en) | 2010-09-28 | 2014-03-27 | President And Fellows Of Harvard College | Cardiac glycosides are potent inhibitors of interferon-beta gene expression |
CN101999627A (en) | 2010-09-29 | 2011-04-06 | 重庆合川盐化工业有限公司 | Hot pot seasoning salt |
WO2012060845A1 (en) | 2010-11-05 | 2012-05-10 | University Of Cincinnati | Methods of preventing ischemic injury using peripheral nociceptive stimulation |
CN102058082B (en) | 2010-11-22 | 2012-10-03 | 晨光生物科技集团股份有限公司 | Efficient extraction and separation technology for effective ingredients of peppers |
CN101974399A (en) | 2010-11-24 | 2011-02-16 | 曹光荣 | Functional white wine and preparation method thereof |
KR101253041B1 (en) | 2010-12-03 | 2013-04-10 | 송인상 | Manufacturing method of processed salt using medicinal plant |
WO2012098281A2 (en) | 2011-01-19 | 2012-07-26 | Universidad Miguel Hernández De Elche | Trp-receptor-modulating peptides and uses thereof |
KR101324926B1 (en) | 2011-01-28 | 2013-11-01 | 계명대학교 산학협력단 | Manufacturing Mathod of Ginger Extract And Ginger Extract Using The Same |
KR20120090359A (en) | 2011-02-07 | 2012-08-17 | 한국식품연구원 | Method for extraction of zingiberene in ginger |
EP3363437B8 (en) | 2011-02-18 | 2021-11-03 | Endo Pharmaceuticals Inc. | Aminoindane compounds and use thereof in treating pain |
EP2684468A4 (en) * | 2011-03-07 | 2014-08-27 | Ajinomoto Kk | Salty taste enhancer |
US8840938B2 (en) | 2011-04-13 | 2014-09-23 | W. Matthew Warnock | Bioavailability enhancing composition |
JP5872187B2 (en) * | 2011-05-17 | 2016-03-01 | 小川香料株式会社 | Salt enhancer |
KR20130003452A (en) | 2011-06-30 | 2013-01-09 | 목포대학교산학협력단 | A method of lite salt |
WO2013009827A1 (en) | 2011-07-13 | 2013-01-17 | Tempero Pharmaceuticals, Inc. | Methods of treatment |
JP2013018764A (en) | 2011-07-14 | 2013-01-31 | Kao Corp | Epithelial sodium channel activator |
CN102326768B (en) | 2011-07-29 | 2013-07-31 | 天津春发生物科技集团有限公司 | Savory flavoring |
DK2749179T3 (en) | 2011-08-26 | 2019-07-15 | Kohjin Life Sciences Co Ltd | Yeast extract with flavor enhancing effect |
EA029151B1 (en) | 2011-09-06 | 2018-02-28 | Курна, Инк. | TREATMENT OF DISEASES RELATED TO ALPHA SUBUNITS OF VOLTAGE-GATED SODIUM CHANNELS (SCNxA) WITH SMALL MOLECULES |
EP2578210A1 (en) | 2011-10-05 | 2013-04-10 | ATB Innovation Ltd. | Rottlerin for the treatment of pulmonary hypertension and related diseases and disorders |
WO2013052844A1 (en) | 2011-10-07 | 2013-04-11 | Pulmatrix, Inc. | Methods for treating and diagnosing respiratory tract infections |
KR20140076629A (en) | 2011-10-20 | 2014-06-20 | 크로모셀 코포레이션 | Compounds, compositions, and methods for reducing or eliminating bitter taste |
EP2771320B1 (en) | 2011-10-24 | 2016-06-22 | Endo Pharmaceuticals Inc. | Cyclohexylamines |
GB201118481D0 (en) | 2011-10-26 | 2011-12-07 | Givaudan Sa | Organic compounds |
GB2496898B (en) | 2011-11-25 | 2020-10-28 | Petroliam Nasional Berhad Petronas | Corrosion inhibition |
KR20130076905A (en) | 2011-11-28 | 2013-07-09 | 김광순 | Dry seaweed flavoring natural seasonings for food. Anchovy salt manufacturing method |
WO2013085014A1 (en) | 2011-12-06 | 2013-06-13 | 日本水産株式会社 | Taste-improving agent and food or drink containing same |
CN102423352B (en) | 2011-12-13 | 2013-10-09 | 广东众生药业股份有限公司 | Preparation method of Chinese medicinal granules for treating cardio-cerebrovascular diseases |
JP5906541B2 (en) | 2011-12-22 | 2016-04-20 | 国立大学法人高知大学 | Gingerol-containing composition |
UA112671C2 (en) | 2011-12-23 | 2016-10-10 | Нестек С.А. | METHOD OF OBTAINING TASTE AND AROMATIC COMPOSITION WITH TASTE AND Aroma OF MIND |
KR101268782B1 (en) | 2011-12-29 | 2013-05-29 | 세종대학교산학협력단 | Preparation method of salt trapped in mushroon mycelium cell wall and noodle containing the same |
WO2013103031A1 (en) | 2012-01-06 | 2013-07-11 | 株式会社カネカ | Salty taste enhancer |
JP3179252U (en) | 2012-07-13 | 2012-10-25 | 株式会社美多加堂 | Powdered salt for processed foods |
CN102763829A (en) * | 2012-07-24 | 2012-11-07 | 朱建辉 | Production process of spicy distillers' grains mixture |
CN102987068A (en) | 2012-10-10 | 2013-03-27 | 合肥永生禽业有限责任公司 | Pig feed capable strengthening appetite and preparation method of pig feed |
CN102987123A (en) | 2012-10-10 | 2013-03-27 | 合肥永生禽业有限责任公司 | Silkworm excrement pig feed and preparation method thereof |
CN102987128A (en) | 2012-10-10 | 2013-03-27 | 合肥永生禽业有限责任公司 | Pagoda tree flower pig feed additive |
CN102934746B (en) | 2012-10-13 | 2013-09-25 | 安徽泗县成安牧业科技有限公司 | Fermentation plant leaf breeding pig feed |
CN102907615A (en) | 2012-10-25 | 2013-02-06 | 沈阳田东科研有限公司 | Making method of braised chicken soup noodles |
CN102948645B (en) | 2012-10-29 | 2013-11-06 | 合肥市益农养殖有限公司 | Mulberry duck feed and preparation method thereof |
CN102972558A (en) | 2012-12-05 | 2013-03-20 | 袁辉 | Process for manufacturing heat-clearing and hypertension-reducing tea |
CN102972552A (en) | 2012-12-05 | 2013-03-20 | 袁辉 | Heat-clearing and hypertension-reducing tea |
WO2014124222A1 (en) * | 2013-02-08 | 2014-08-14 | General Mills, Inc. | Reduced sodium food products |
CN103141575A (en) | 2013-03-15 | 2013-06-12 | 南京师范大学 | Method for preparing hawthorn yogurt being rich in angiotensin-converting enzyme inhibition peptides |
-
2014
- 2014-02-07 WO PCT/US2014/015244 patent/WO2014124222A1/en active Application Filing
- 2014-02-07 JP JP2015557084A patent/JP2016509830A/en active Pending
- 2014-02-07 ES ES18201716T patent/ES2925071T3/en active Active
- 2014-02-07 WO PCT/US2014/015227 patent/WO2014124212A1/en active Application Filing
- 2014-02-07 ES ES18164825T patent/ES2831028T3/en active Active
- 2014-02-07 CA CA2900710A patent/CA2900710C/en active Active
- 2014-02-07 EP EP20175617.8A patent/EP3732994B1/en active Active
- 2014-02-07 CA CA2900707A patent/CA2900707C/en active Active
- 2014-02-07 CN CN201480019853.8A patent/CN105189460B/en active Active
- 2014-02-07 WO PCT/US2014/015234 patent/WO2014124216A1/en active Application Filing
- 2014-02-07 EP EP18201716.0A patent/EP3466930B1/en active Active
- 2014-02-07 CA CA3081195A patent/CA3081195C/en active Active
- 2014-02-07 WO PCT/US2014/015240 patent/WO2014124220A1/en active Application Filing
- 2014-02-07 WO PCT/US2014/015230 patent/WO2014124214A1/en active Application Filing
- 2014-02-07 ES ES20175617T patent/ES2936634T3/en active Active
- 2014-02-07 ES ES14705944.8T patent/ES2671954T3/en active Active
- 2014-02-07 FI FIEP20175617.8T patent/FI3732994T3/en active
- 2014-02-07 ES ES14705945.5T patent/ES2675018T3/en active Active
- 2014-02-07 DK DK18164825.4T patent/DK3366677T3/en active
- 2014-02-07 EP EP14705945.5A patent/EP2954037B1/en active Active
- 2014-02-07 WO PCT/US2014/015216 patent/WO2014124205A1/en active Application Filing
- 2014-02-07 DK DK18201716.0T patent/DK3466930T3/en active
- 2014-02-07 WO PCT/US2014/015200 patent/WO2014124193A1/en active Application Filing
- 2014-02-07 DK DK14705944.8T patent/DK2953934T3/en active
- 2014-02-07 CN CN201810631692.8A patent/CN108902893B/en active Active
- 2014-02-07 WO PCT/US2014/015192 patent/WO2014124191A1/en active Application Filing
- 2014-02-07 DK DK14705945.5T patent/DK2954037T3/en active
- 2014-02-07 DK DK14705458.9T patent/DK2984073T3/en active
- 2014-02-07 EP EP14705944.8A patent/EP2953934B1/en active Active
- 2014-02-07 WO PCT/US2014/015220 patent/WO2014124207A1/en active Application Filing
- 2014-02-07 PT PT147059455T patent/PT2954037T/en unknown
- 2014-02-07 PT PT147054597T patent/PT2956440T/en unknown
- 2014-02-07 CN CN202010439403.1A patent/CN111557432B/en active Active
- 2014-02-07 EP EP14705459.7A patent/EP2956440B1/en active Active
- 2014-02-07 PT PT201756178T patent/PT3732994T/en unknown
- 2014-02-07 BR BR112015018847A patent/BR112015018847A2/en not_active Application Discontinuation
- 2014-02-07 JP JP2015557085A patent/JP2016506747A/en active Pending
- 2014-02-07 DK DK20175617.8T patent/DK3732994T3/en active
- 2014-02-07 DK DK14705459.7T patent/DK2956440T3/en active
- 2014-02-07 ES ES14705458T patent/ES2704880T3/en active Active
- 2014-02-07 PT PT182017160T patent/PT3466930T/en unknown
- 2014-02-07 EP EP14705458.9A patent/EP2984073B1/en active Active
- 2014-02-07 US US14/766,557 patent/US11540539B2/en active Active
- 2014-02-07 PT PT181648254T patent/PT3366677T/en unknown
- 2014-02-07 PT PT14705458T patent/PT2984073T/en unknown
- 2014-02-07 ES ES14705459.7T patent/ES2675215T3/en active Active
- 2014-02-07 EP EP18164825.4A patent/EP3366677B1/en active Active
- 2014-02-07 PT PT147059448T patent/PT2953934T/en unknown
- 2014-02-07 WO PCT/US2014/015239 patent/WO2014124219A1/en active Application Filing
- 2014-02-07 WO PCT/US2014/015223 patent/WO2014124209A1/en active Application Filing
- 2014-02-07 WO PCT/US2014/015207 patent/WO2014124198A1/en active Application Filing
- 2014-02-07 CN CN201480019810.XA patent/CN105164245B/en active Active
- 2014-02-07 WO PCT/US2014/015211 patent/WO2014124201A1/en active Application Filing
- 2014-02-07 BR BR112015018948A patent/BR112015018948A2/en not_active Application Discontinuation
-
2015
- 2015-08-07 US US14/820,891 patent/US10159268B2/en active Active
-
2018
- 2018-11-21 US US16/197,550 patent/US20190090520A1/en not_active Abandoned
- 2018-12-12 JP JP2018232143A patent/JP7188999B2/en active Active
-
2019
- 2019-07-16 JP JP2019130844A patent/JP6982599B2/en active Active
-
2020
- 2020-05-18 US US16/877,126 patent/US20200281236A1/en active Pending
-
2021
- 2021-11-19 JP JP2021188840A patent/JP2022027792A/en active Pending
-
2024
- 2024-01-22 JP JP2024007208A patent/JP2024045277A/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2675018T3 (en) | Sodium Reduced Food Products | |
WO2020033669A8 (en) | Antagonists of t2r54 and compositions and uses thereof | |
EA200702421A1 (en) | SUBSTITUTED BY GASOLINE SERIN-AMIDA | |
MY159705A (en) | Plant disease control composition and method for controlling plant disease by applying the same | |
RU2011144143A (en) | PEPTIDE USE FOR GIVING KOKUMI | |
SG160335A1 (en) | Heterocyclic compounds as sweetener enhancers | |
WO2018005806A3 (en) | Methods and microorganisms for producing flavors and fragrance chemicals | |
EA201000997A1 (en) | TEA COMPOSITION AND METHOD FOR ITS PRODUCTION | |
WO2009095798A3 (en) | Formulas comprising calcium, magnesium, zinc, and vitamin d3 for the prevention and amelioration of osteoporosis | |
CN106235293A (en) | A kind of Wasabia japonic (Euterma Wasabi) barbecue sauce and preparation method thereof | |
MX2022000996A (en) | Novel steviol glycoside, method for producing same, and sweetener composition containing same. | |
DE602006015630D1 (en) | Thiole als aromastoffe | |
CN102775518A (en) | Chitosan succinate flavor enhancer | |
KR20110040060A (en) | Process for the preparation of salted anchovy containing rubus coreanus miquel and salted anchovy containing rubus coreanus miquel prepared therefrom | |
JP2015133951A (en) | Method for manufacturing fried food using deep ocean water | |
WO2017186973A3 (en) | Blends containing enantiomerically pure ambrocenide® | |
CN104450309A (en) | Non-toxic cleaning agent | |
BRPI0606385A2 (en) | method for imparting, accentuating, ameliorating or modifying the flavor or taste properties of a flavoring composition or a flavored article, composite, composite flavoring composition, and flavored article | |
CN102775521A (en) | Chitosan guanylate flavor enhancer | |
Kan et al. | Essential oil yield and compositions of endemic mountain tea (Sideritis libanotica Labill. ssp. linearis (Bentham) Borm. and Sideritis bilgerana PH Davis) cultivated in Konya ecological conditions of Turkey | |
DE60302607D1 (en) | Composition for the treatment of whole muscle product and process for the preparation of a whole muscle product with this composition | |
CN102775522B (en) | Chitosan inosine silicate flavoring agent | |
MX340335B (en) | Organic compounds. | |
JP2010528631A (en) | Salty taste enhancement | |
KR20070112319A (en) | Method for preparing red radish pickle |